Background
==========

Decades of research have helped mitigate numerous sources of error in phase contrast MRI (PC-MRI), nevertheless chemical shift induced phase errors (CS errors) and spatiotemporal undersampling errors (STU errors) remain critical sources of error for which a cogent error mitigation strategy is needed. CS errors, which arise in PC-MRI because the complex signal for perivascular fat chemically shifts across the vessel wall and corrupts the complex blood signal, can be mitigated with an in-phase TE (TE~IN~) and a high receiver bandwidth \[[@B1]\]. STU errors arise from suboptimal spatiotemporal resolution. The objective was to design a PC-MRI sequence with improved sequence efficiency and evaluate the impact on mitigating both CS and STU errors.

Methods
=======

Hargreaves et al. \[[@B2]\] have shown that convex optimization (CVX) can be used to minimize gradient waveform durations subject to both hardware constraints (maximum available gradient amplitude and slew rate) and pulse sequence constraints (e.g. VENC, RF pulse, slice thickness, FOV, bandwidth, matrix size). We developed CVX PC-MRI to achieve improved spatiotemporal resolution to reduce STU errors while using the minimum TE~IN~(TE~IN,MIN~) to reduce CS errors for a fixed breath hold duration. Flow measurements were obtained at 3T (Siemens Trio) using a conventional flow compensated and flow encoded (FCFE) PC-MRI sequence and CVX PC-MRI optimized for high spatial resolution (CVX-SR) or high temporal resolution (CVX-TR). All sequences mitigated CS errors with a high receiver bandwidth and TEIN. CVX permits using TE~IN,MIN~= 2.46 ms while the FCFE sequence can only achieve TE~IN~= 4.92 ms. Total flow and peak velocity measurements were acquired in the ascending aorta (aAo), main pulmonary artery (PA), and right/left pulmonary arteries (RPA/LPA) of ten (N = 10) normal volunteers (Table [1](#T1){ref-type="table"}).

###### 

PC-MRI parameters.

                                FCFE                                    CVX-SR      CVX-TR
  ----------------------------- --------------------------------------- ----------- -----------
  TE~IN~/TR (ms)                4.92/7.00                               2.46/4.00   2.46/3.95
                                                                                    
  Temporal resolution (ms)      55.9                                    56.1        31.6
                                                                                    
  VENC (cm/s)                   150                                     150         150
                                                                                    
  Parallel acceleration         rate-2 GRAPPA with 24 reference lines               
                                                                                    
  Flip angle (degrees)          30                                      30          30
                                                                                    
  Segments                      4                                       7           4
                                                                                    
  FOV (mm)                      340 × 255                               340 × 255   340 × 255
                                                                                    
  Pixel number                  192 × 144                               288 × 216   192 × 144
                                                                                    
  Pixel size (mm)               1.8 × 1.8                               1.2 × 1.2   1.8 × 1.8
                                                                                    
  Bandwidth (Hz/px)             814                                     827         814
                                                                                    
  Duration (heart beats)        23                                      20          23
                                                                                    
  Acquired cardiac phases ^†^   13-18                                   13-18       23-32

^†^The number of acquired cardiac phases is heart rate dependent

Results
=======

The sequence efficiencies (readout duration/TR) were 17.7% for FCFE, 30.5% for CVX-SR, and 31.4% for CVX-TR. Measurements of total flow and peak velocity were significantly higher (P \< 0.05) for CVX-SR and CVX-TR compared to FCFE (Table [2](#T2){ref-type="table"}). On average, CVX-SR measured 8.1% higher total flow and 3.8% higher peak velocity and CVX-TR measured 5.1% higher total flow and 10.5% higher peak velocity.

###### 

In vivo (N = 10) PC-MRI measures of total flow and peak velocity.

                         FCFE           CVX-SR            CVX-TR
  ---------------------- -------------- ----------------- -------------------
  **Total Flow (mL)**                                     
                                                          
  aAo                    89.0 ± 18.2    95.9 ± 19.4^†^    93.5 ± 17.9^†^
                                                          
  PA                     92.6 ± 18.5    100.1 ± 20.1^†^   97.2 ± 18.0^†,‡^
                                                          
  RPA                    48.1 ± 9.5     52.5 ± 9.9^†^     50.9 ± 9.5^†,‡^
                                                          
  LPA                    44.3 ± 8.7     47.7 ± 10.2^†^    46.4 ± 9.0^†^
                                                          
  Peak Velocity (cm/s)                                    
                                                          
  aAo                    117.2 ± 17.2   121.6 ± 15.3^†^   127.3 ± 15.8^†,‡^
                                                          
  PA                     87.0 ± 11.8    90.0 ± 13.5^†^    95.4 ± 15.4^†,‡^
                                                          
  RPA                    93.8 ± 15.9    97.1 ± 16.8^†^    104.7 ± 21.7^†,‡^
                                                          
  LPA                    95.3 ± 18.0    99.7 ± 19.8^†^    107.2 ± 19.9^†,‡^

Data are expressed as mean ± standard deviation ^†^P \< 0.05 shows a statistical significant difference compared to FCFE. ^‡^P \< 0.05 shows a statistical significant difference compared to CVX-SR.

Conclusions
===========

CVX PC-MRI nearly doubles sequence efficiency, reduces CS and STU errors, and produces more accurate measurements of blood flow and peak velocity. CVX-SR reports the highest total flow and CVX-TR reports the highest peak velocities, but further improvements in spatiotemporal resolution may still be needed for accurate quantification.
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